MAVERICK CAPITAL LTD 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 8,261,242 5.400% |
-186,562 (-2.21%) |
Filing |
| 2024-02-14 5:02 pm Purchase |
2023-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 8,447,804 6.900% |
1,350,140 (+19.02%) |
Filing |
| 2023-02-14 11:53 am Purchase |
2022-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 7,097,664 8.200% |
1,504,275 (+26.89%) |
Filing |
| 2022-02-14 3:07 pm Purchase |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 5,593,389 9.500% |
5,593,389 (New Position) |
Filing |